Article
Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages
28 Mar 2022
Abstract excerpt
Leucine-rich-repeat kinase 2 (LRRK2), a potential therapeutic target for the treatment of Parkinson's disease (PD), is highly expressed in monocytes and macrophages and may play a role in the regulation of inflammatory pathways. To determine how LRRK2 protein levels and/or its activity modulate inflammatory cytokine/chemokine levels in human immune cells, isogenic human induced pluripotent stem cells (iPSC) with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
